Healthcare provider profile · identity verified

Paul Michael Bisson, M.D

Internal Medicine · BRONX, NY · NPI 1649484163

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	763	202
Metformin Hcl	Metformin Hcl	368	96
Amlodipine Besylate	Amlodipine Besylate	360	96
Levothyroxine Sodium	Levothyroxine Sodium	295	80
Losartan Potassium	Losartan Potassium	294	79
Metoprolol Succinate	Metoprolol Succinate	276	73
Omeprazole	Omeprazole	238	79
Gabapentin	Gabapentin	218	46
Lisinopril	Lisinopril	216	57
Eliquis	Apixaban	208	41
Furosemide	Furosemide	165	46
Albuterol Sulfate Hfa	Albuterol Sulfate	158	53
Meloxicam	Meloxicam	158	55
Simvastatin	Simvastatin	143	48
Zolpidem Tartrate	Zolpidem Tartrate	135	24
Sertraline Hcl	Sertraline Hcl	134	29
Fluticasone Propionate	Fluticasone Propionate	130	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	128	17
Carvedilol	Carvedilol	119	25
Escitalopram Oxalate	Escitalopram Oxalate	119	28
Jardiance	Empagliflozin	119	32
Rosuvastatin Calcium	Rosuvastatin Calcium	119	33
Tamsulosin Hcl	Tamsulosin Hcl	118	34
Mirtazapine	Mirtazapine	112	20
Nifedipine Er	Nifedipine	110	27
Lorazepam	Lorazepam	104	20
Prednisone	Prednisone	100	67
Alprazolam	Alprazolam	91	12
Clopidogrel	Clopidogrel Bisulfate	91	24
Montelukast Sodium	Montelukast Sodium	90	30
Baclofen	Baclofen	86	33
Memantine Hcl	Memantine Hcl	79	15
Metoprolol Tartrate	Metoprolol Tartrate	79	25
Famotidine	Famotidine	78	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	74	59
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	14
Ibuprofen	Ibuprofen	69	25
Trulicity	Dulaglutide	67	16
Atenolol	Atenolol	66	18
Levetiracetam	Levetiracetam	63	11
Oxycodone Hcl	Oxycodone Hcl	63	12
Azithromycin	Azithromycin	60	49
Hydrochlorothiazide	Hydrochlorothiazide	55	21
Synthroid	Levothyroxine Sodium	53	18
Clonazepam	Clonazepam	50	12
Glimepiride	Glimepiride	47	15
Januvia	Sitagliptin Phosphate	47	13
Naproxen	Naproxen	47	18
Triamcinolone Acetonide	Triamcinolone Acetonide	47	17
Enalapril Maleate	Enalapril Maleate	46	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	15
Donepezil Hcl	Donepezil Hcl	43	suppressed
Calcium Acetate	Calcium Acetate	42	suppressed
Glipizide Er	Glipizide	42	suppressed
Ozempic	Semaglutide	42	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	42	18
Mounjaro	Tirzepatide	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	40	12
Allopurinol	Allopurinol	39	14
Clotrimazole	Clotrimazole	38	16
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	29
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Albuterol Sulfate	Albuterol Sulfate	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Divalproex Sodium	Divalproex Sodium	30	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Carbamazepine	Carbamazepine	29	suppressed
Valsartan	Valsartan	29	suppressed
Ezetimibe	Ezetimibe	28	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Finasteride	Finasteride	27	suppressed
Latanoprost	Latanoprost	27	11
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	suppressed
Diazepam	Diazepam	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	16
Olanzapine Odt	Olanzapine	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	15
Ketoconazole	Ketoconazole	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Ramipril	Ramipril	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Meclizine Hcl	Meclizine Hcl	22	14
Novolog Flexpen	Insulin Aspart	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	18
Potassium Chloride	Potassium Chloride	21	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	21	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Nystatin	Nystatin	20	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	18
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	14
Single Use Swab	Alcohol Antiseptic Pads	18	suppressed
Trazodone Hcl	Trazodone Hcl	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Felodipine Er	Felodipine	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Methimazole	Methimazole	17	suppressed
Nystop	Nystatin	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Rhopressa	Netarsudil Mesylate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Brinzolamide	Brinzolamide	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	12
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	11
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Colchicine	Colchicine	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	11
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error